INTRODUCTION
A typical hospital laboratory processes 1.1 million specimens each year. Approximately 80% of these specimens require pre-analytical preparation. Specimen preparation is the unresolved challenge facing today's laboratory. Pre-analytical specimen preparatory functions include the steps from specimen collection to its transfer to a laboratory work station or work cell. Specimen preparation is complex, hazardous, and crucial and is not necessarily well controlled. There are over 60 decision points in this process.
CENTRIFUGATION
Centrifugation is a traditional separation method for preparing analytical specimens. It is not the ideal method. About 75% of specimens are centrifuged. Centrifugation is the major delay in the laboratory's workflow. Specimen flow varies throughout the workday. Consequently, specimens are batched because centrifuges are in use; or delayed to collect a sufficient number of specimens to centrifuge. The result, in both cases, is delay. Each delay lengthens intra laboratory turn-around-time. Like other methods used in the laboratory, centrifugation of specimens must follow specific procedures to achieve acceptable results. Centrifugation of whole blood to produce plasma or serum specimens for analyses can not exceed an RCF of 1500XG for more than fifteen
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Key Steps In Pre-Analytical Specimen Preparation
(Based on College of American Pathologists Workload Recording System)
Centrifugation As A Component Of Specimen Preparation
Specimen separation and its related functions comprise a substantial portion of the pre-analytical processes. It is also a major contributing factor in intra-laboratory turn-around-time.
(15), minutes without disrupting cellular integrity, thereby affecting test results. This precludes the use of high-speed short time centrifugation, or 'STAT' centrifuges.
Unlike other laboratory procedures, the acceptability of a centrifuged specimen can only be determined at the end of the cycle or in the subsequent analytic phase. The lack of quality control processes for centrifugation result in variable specimen quality.
Centrifugation imposes significant limitations on the laboratory, affecting the general workflow. These limitations include: Using this technology, a plasma sample is ready for analysis by standard test methodology in less than 30 seconds. Specimen volume and acceptability are also measured within the 30 seconds. In addition to the rapid separation, plasma separated in this manner is virtually free of cells, membrane fragments, cellular debris and cell contents. Such plasmas are, therefore, better suited for analysis than those prepared by centrifugation.
THE MICROFILTRATION PROCE SS
Microfiltration is the separation of particles that range between 0.01µm and 20µm in size.
For the rapid separation of plasma from blood, a specimen is transferred between two reservoirs, flowing over a microporous membrane in alternating directions. By moving the specimen back and forth across the membrane, the membrane surface is continuously cleaned. This keeps the filtration efficiency at its peak throughout the separation process. As a result, very low pressure is required for precise control of the specimen flow and precludes cell disruption or migration. Plasma containing clinically significant analytes rapidly crosses the membrane. Typical anticoagulants do not affect the rate of microfiltration or the plasma volume. The maximum volume of microfiltered plasma is about a third of the whole blood specimen.
Microfiltration is the validated alternative technology to centrifugation. It allows rapid separation of analytical quality plasma directly from the unopened primary collection tube.
FILTRATION CELLS
A disposable filtration cell is the key component in the microfiltration process. The configuration of filtration cells can vary with its applications. Control and functions of the filtration remain the same. These include:
-whole blood reservoir -microfiltration -plasma collection -specimen acceptability cuvette -analytical cuvette (in certain applications)
The components of a filtration cell are illustrated below.
Microfiltration Cell Description
The filter cell has four optical paths. Two in each chamber. One high and one low level. These sense blocked (specimine present) and clear (no specimen present). In the illustrations, green indicates clear and black indicates blocked.
The diagram on the following page illustrates the microfiltration process and its controlling optical pathway. Each step takes about one second
Components Of Laboratory Labor (%)
Specimen preparation is a resource intensive function. The pre-analytical processes consumes approximately 65% of the laboratory labor. Recent efforts to address these challenges have been limited to mechanizing traditional practices and methods.
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The Microfiltration Process Microfiltration eliminates the limitations and time delays inherent in centrifuge separation. Because they are virtually free of cells, cellular debris and contents, microfiltered specimens offer certain analytical advantages. This is important when assay detection methods are based on particle size or absence of cells, presence, or optical properties. Recovery studies on analytes over a wide range of molecular size, weight, surface properties and detection limits averaged 99.7% on microfiltered plasma.
Specimen Preparation Method Comparison

REQUIRED STEPS METHOD
Effects Of Separation Methods On Plasma
SPECIMEN ACCEPTABILITY
The design of the filtration cells provide the opportunity to check the quality or acceptability of and measure the plasma volume. Bio/Data Corporation has developed an integral subsystem and software to perform these functions within the filtration cycle time. This function is called the Compromised Specimen Alert System.
Plasma is optically scanned for hemolysis, icterus and lipemia. Clots are detected through the flow control system. This compromised specimen alert system notifies the operator when specimens are not acceptable for analysis.
Additionally, the volume of plasma separated can be precisely measured or simply monitored.
MICROFILTRATION TECHNOLOGY SUMMARY
Microfiltration Technology is the alternative to specimen preparation by centrifugation. 
INNOVATIVE:
MICROFILTRATION SYSTEM
The primary components of a microfiltration system are:
-Filtration Station -Optical Systems -System and Control Software -Disposable Filtration Cells A microfiltration system can be used in conjunction with automated, cap piercing or non-automated sample transfer systems. The small foot print of a microfiltration station allows for very flexible applications. A microfiltration system can be:
-Bench Top (accessory) -Integral to an Analyzer -Incorporated in a Workcell
Bench Top: These applications include plasma separation for clinical, analytical or therapeutic use. The system is small, discrete and for general purpose use.
Integral to an Analyzer: These applications provide rapid, measured and cell free plasma for immediate analysis. The microfiltration system is part of the analyzer. Filtration cells are application specific. Its flexible configuration accommodates a wide range of sample transfer mechanisms.
Workcell: Microfiltration Technology can be used with the Company's automated sample transfer system or with those of other manufacturers. Combined with the specimen acceptability functions, work-cells can function continuously rather than in batch mode.
Microsample Coagulation Analyzer™
Model MCA 310
Microfiltration Sampling System
POTENTIAL APPLICATIONS FOR MICROFILTRATION TECHNOLOGY
This technology can be applied in three distinct areas:
-Analytical -Clinical -Therapeutic
Within each of these areas, there are a number of individual applications.
The following charts outline selected application areas currently being developed.
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MICROFILTRATION EVALUATION PROGRAM THE PROGRAM:
Companies wishing to qualify microfiltration technology for a specified purpose can do so through this program. -Power Requirements must be specified on your Purchase Order.
TERMS & CONDITIONS:
-An executed Non Disclosure Agreement is required.
-Application description and a summary of test results must be provided to Bio/Data Corporation. -Agreed payment must accompany your order. Outgoing freight and insurance will be prepaid and invoiced upon shipment. -On site support by a Bio/Data Corporation engineer is available. -The module must be returned with freight and insurance prepaid at the end of the evaluation period.
LICENSING PROGRAM
Bio/Data Corporation has successfully developed and applied microfiltration technology for the rapid separation of biological samples since 1985. It has developed a body of intellectual proper-ties including multi-national-patents, know-how and expertise in the practices and applications of microfiltration.
The Company has developed a licensing program for its technology. This includes: -Microfiltration Technology -Software -Compromised Sample Alert System -Sample Transfer System -Automated Assembly Equipment Licenses are only granted on a selective basis. Each licensee will be obliged to take a basic license. Content, limitations, and other terms and conditions will then be negotiated depending on the requirements of the license. 
